Understanding the PPR signaling in T cells and the cross-talk between T cells and SCs may thus yield novel therapeutic strategies for PTH-induced bone disease and may help understand the pathophysiology of bone loss associated with immune disorders. Here, PTH is linked to immune system disorder.